Patent directory · USPTO A61K / A61P
Patents matching “The Board of Regents of the University of Texas”
1,756 pharma patents match "The Board of Regents of the University of Texas" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 1,756 pharmaceutical patents matching "The Board of Regents of the University of Texas" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 10378058
Diagnostic and therapeutic methods and compositions involving PTEN and breast cancer
granted -
US 10377796
Inhibition of pulmonary fibrosis with nutlin-3a and peptides
granted -
US 10379109
Systems and methods for high-resolution imaging
granted -
US 10369103
Neuroprotective liposome compositions and methods for treatment of stroke
granted -
US 10370360
Small-molecule inhibitors targeting discoidin domain receptor 1 and uses thereof
granted -
US 10363311
Engineered primate cystine/cysteine degrading enzymes as antineogenic agents
granted -
US 10363319
Glycoconjugates and methods for their use
granted -
US 10363248
Salts of heterocyclic modulators of HIF activity for treatment of disease
granted -
US 10363245
Methods for treating CNS lesions
granted -
US 10363261
Enolase inhibitors and methods of treatment therewith
granted -
US 10358439
DNA binding agents with a minor groove binding tail
granted -
US 10358501
HER3 specific monoclonal antibodies for diagnostic and therapeutic use
granted -
US 10357464
Methods for delivering volatile anesthetics for regional anesthesia and/or pain relief
granted -
US 10358419
1,3-dipolar [70]fulleropyrrolidinium iodide derivatives
granted -
US 10357448
Echogenic vehicle for clinical delivery of plasminogen activator and other fibrin-binding therapeutics to thrombi
granted -
US 10351522
Sulfonamide derivative and pharmaceutically acceptable acid addition salt thereof
granted -
US 10344025
GLS1 inhibitors for treating disease
granted -
US 10345310
Diagnostic test for early stage cancer
granted -
US 10342822
Method of producing physiological and therapeutic levels of nitric oxide through an oral delivery system
granted -
US 10335476
Vaccine to protect against Ehrlichia infection
granted -
US 10335470
Immunogenic compositions comprising progastrin and uses thereof
granted -
US 10336786
Pharmaceutical targeting of a mammalian cyclic di-nucleotide signaling pathway
granted -
US 10335382
Use of hydrogen sulfide synthesis inhibitors for cancer therapy
granted -
US 10330600
Plasmonic-magnetic bifunctional nanotubes for biological applications
granted